Xylo Technologies Ltd

Xylo Technologies Ltd (XYLO) Stock Analysis

$5.070

0.000 (0.00%)At close

Loading chart…
High
5.119
Open
5.070
VWAP
5.09
Vol
5.15K
Mkt Cap
Low
5.070
Amount
26.18K
EV/EBITDA, TTM
0.00

Xylo Technologies Ltd, formerly known ad Medigus Ltd, is an Israel-based medical device company specializing in developing minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The Company developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD).

medigus.com

Valuation Metrics

The current forward P/E ratio for Xylo Technologies Ltd (XYLO) is 0.84, compared to its 5-year average forward P/E of -6.37.

Forward P/E

Fair
5Y Average P/E
-6.37
Current P/E
0.84
Overvalued
21.35
Undervalued
-34.08

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued
0.00
Undervalued
0.00

Forward P/S

Fair
5Y Average P/S
0.66
Current P/S
0.03
Overvalued
2.26
Undervalued
-0.93

Events Timeline

2025-12-01 (ET)

08:50:00

SciSparc Acquires 19.99% Stake in Xylo's Patent Portfolio for Innovative Medical Systems

2025-06-05 (ET)

09:25:38

Xylo Technologies says Viewbix shares to begin trading on Nasdaq

2025-04-30 (ET)

09:21:46

Xylo announces Charging Robotics installed system for wireless charging

2025-04-10 (ET)

09:27:26

Xylo Technologies announces Revoltz launches commercial phase of PORTO EV

News

XYLO FAQ — answered by Alphio AI

Xylo Technologies Ltd, formerly known ad Medigus Ltd, is an Israel-based medical device company specializing in developing minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The Company developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD). It operates in the Healthcare sector (COMPUTER PROCESSING AND DATA PREPARATION AND PROCE industry).

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started